New Grants Awarded Infectious Diseases and International Health

Eric Houpt

Contract for $149,996 from CDC for “Testing of Etiological Agents for Acute Febrile Illness in Tanzania”, effective 4/10/2014 – 9/8/2014.  This will use the AFI card Jie Liu developed for testing 1,000 outbreak specimens from across Tanzania where CDC surveillance has no clear etiology.

Cirle Warren

Grand Challenges Explorations Grant entitled “3-D Human Small Intestinal Organoid for Enteric Infections”, which has been funded for $100,000, making her eligible for follow-on substantial phase II funding.

Paul Hoffman

R21/33 awarded 03/01/14 – 02/29/16: “PFOR Inhibitor Amixicile for Treatment of Drug Resistant Parasites and Bacteria”. Total funding for 2 years: $434,500.

Richard Guerrant, Rebecca Dillingham

Dr. Guerrant as PI and Drs. Dillingham and Bessong at Co-Directors have received a competitive renewal (year 11) of the GIDRT / Global Infectious Disease Training Program at UVA with a start date of 4/12/14. Direct funds are $178,565 per year for 5 years. Previously the grant was with Federal University of Ceara in Brazil, which lost its status as an LMIC, so the grant was switched to the University of Venda in South Africa. This will support ~ 4 pre and post docs to come to UVA.

Erica Buonomo

Individual predoctoral NRSA. Erica will for her PhD dissertation build on her observation published in the Journal of Infectious Diseases that IL-23 is disease enhancing in C. difficile. The title of her award is “The Role of IL-23 in the Pathogenesis of Clostridium difficile Infection.” Bill Petri is her mentor.  athe award runs from 07/01/2014 – 06/30/2017. Total for three years is $93,981.

Poonum Korpe

The title of her K23 early career award is “Passive and Acquired Immunity to Cryptosporidiosis in Bangladeshi Children.” Bill Petri is her mentor and the award runs from 07/01/2014 – 06/30/2019. Total award for five years is $871,790.

Bill Petri

Bill & Melinda Gates Foundation (subcontract from icddr,b, Bangladesh) for natural history study of cryptosporidiosis in infants ($750,000 total for 3 years). This will test the impact of cryptosporidial diarrhea in infants from urban and rural sites in Bangladesh, including the role of host genetic susceptibility and parasite genetic diversity.